| X | Filing Date | Trade Date | Ticker | Insider Name | Title | Trade Type | Price | Qty | Owned | ΔOwn | Value | 1d | 1w | 1m | 6m | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-14 | BIOBI | Crowley Michael | EVP, GBL Commercial Operations | S - Sale+OE | $247.06 | -3,000 | 8,171 | -27% | -$741,184 | |||||
| D | 2024-09-06 | BIOBI | Last Andrew J. | EVP, COO | S - Sale+OE | $329.94 | -3,000 | 7,559 | -28% | -$989,815 | |||||
| D | 2024-09-04 | BIOBI | Barry James | EVP, Pres, LSG | S - Sale+OE | $330.50 | -623 | 147 | -81% | -$205,898 | |||||
| 2024-06-13 | BIOBI | Crowley Michael | EVP, GBL Commercial Operations | S - Sale | $281.91 | -369 | 6,573 | -5% | -$104,023 | ||||||
| 2023-05-03 | BIOBI | Schwartz Steven D | 10% | S - Sale | $463.86 | -320 | 4,461,824 | 0% | -$148,435 | ||||||
| D | 2024-02-28 | BIOBI | Ernst Timothy S | EVP, GC, Sec | S - Sale+OE | $330.55 | -2,500 | 3,397 | -42% | -$826,375 | |||||
| D | 2024-02-27 | BIOBI | Crowley Michael | EVP, GBL Commercial Operations | S - Sale+OE | $336.00 | -3,000 | 6,942 | -30% | -$1,008,000 | |||||
| 2023-12-12 | BIOBI | Wright Dara | EVP, Pres, CDG | S - Sale | $299.16 | -1,200 | 1,499 | -44% | -$358,992 | ||||||
| 2023-11-28 | BIOBI | Crowley Michael | EVP, GBL Commercial Operations | S - Sale | $305.10 | -642 | 6,942 | -8% | -$195,874 | 
| A | Amended filing | 
| D | Derivative transaction in filing (usually option exercise) | 
| E | Error detected in filing | 
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price | 
| S - Sale | Sale of securities on an exchange or to another person | 
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) | 
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company | 
| P - Purchase | Purchase of securities on an exchange or from another person |